Metronomic Chemotherapy for Pancreatic Cancer
Learn More About Pancreatic Cancer Metronomic Chemotherapy: Chat with Us | Email Us
Pancreatic Cancer Treatment: Metronomic Chemotherapy
CTCA offers pancreatic cancer patients an innovative chemotherapy treatment option called metronomic chemotherapy.
With metronomic chemotherapy, the anti-cancer drugs are administered in smaller doses over a period of several days, rather than the standard chemotherapy treatment of a single, large dose. By administering the chemotherapy drugs in smaller doses over a period of several days, metronomic chemotherapy has the potential to affect cancerous pancreatic cells as they are dividing.
In addition, the smaller doses can help make the chemotherapy more tolerable for some patients. This approach may help to reduce some of the unpleasant side effects of pancreatic cancer chemotherapy, such as nausea and vomiting.
Metronomic chemotherapy may be a treatment option for pancreatic cancer patients with metastatic cancer, or for those who cannot tolerate a full dosage of chemotherapy at once.
Next Topic: Intra-Arterial Chemotherapy for Pancreatic Cancer
